Company: bluebird bio
Job title: Vice President, Commercial Operations
Matt works with a team of amazing bluebirds and in collaboration with a coalition of invested healthcare providers, patient advocates, and other stakeholders to recode the system so that patients can access transformative gene therapies. Prior to his tenure at bluebird bio, Matt held role of increasing commercial responsibility and impact at Genzyme and Biogen.
Panel Discussion – Assessing the Commercial Realities of Launching Gene Therapies in the Blood Disorder Space 9:30 am
Determining the most effective ways of demonstrating product value Ensuring accessibility of products through co-operation with payers and patients Discussing creative solutions to increase accessibility to patients by overcoming cost and geographic barriersRead more
day: Day One